Problem statement: Answer the multiple-choice question.
Question: Which drug has a -7.503\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
a.) COC(=O)c1cc(Cl)c(NC(=O)Cc2ccccc2)cc1OC
b.) Cc1ccc(-c2cc(C(=O)N(C)CC(=O)Nc3ccccc3Br)c3ccccc3n2)o1
c.) Cc1cc(C)c2c(CN3CCN(Cc4ccccc4)CC3)cc(=O)oc2c1C.Cl
d.) O=C1c2cccc3cc([N+](=O)[O-])cc(c23)C(=O)N1c1nncs1
e.) O=C(Cn1nc2n(c1=O)-c1ccccc1SC2)N/N=C/c1ccncc1
Answer: c. Cc1cc(C)c2c(CN3CCN(Cc4ccccc4)CC3)cc(=O)oc2c1C.Cl
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1cc(C)c2c(CN3CCN(Cc4ccccc4)CC3)cc(=O)oc2c1C.Cl
Cc1cc(C)c2c(CN3CCN(Cc4ccccc4)CC3)cc(=O)oc2c1C.Cl
4-[(4-benzylpiperazin-1-yl)methyl]-5,7,8-trimethylchromen-2-one;hydrochloride